Middle-age obesity may be caused by changes in the shapes of neurons in the brain, impacting the role of MC4Rs
top of page
Browse by category
Search
Middle-age obesity is caused by age-related changes in the shape of neurons in the hypothalamus, a region of the brain that controls...
Metabolic surgery results in cardiometabolic improvements in people with severe obesity
Patients who underwent metabolic surgery had significant improvements in cardiometabolic health, according to researchers from Vanderbilt...
Innovative program connects bariatric surgery and kidney transplant access for patients who have obesity and end-stage renal disease
A collaborative study between bariatric and transplant teams has created a viable pathway for patients with obesity who also have...
Journal Watch 13/3/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Fractyl’s Rejuva platform demonstrates potent and durable effects of a single dose of a human GLP-1 pancreatic gene therapy transgene vs semaglutide for diabetes and obesity
Fractyl Health has revealed promising new preclinical findings for the first clinical candidate in its Rejuva pancreatic gene therapy...
FDA approves Wegovy for CVD risk reduction in people with overweight or obesity and established cardiovascular disease
The FDA has approved a label expansion for Wegovy based on a supplemental New Drug Application (sNDA) for the indication of reducing...
Browse by tag
bottom of page